Home › Compare › DLNDY vs ABBV
DLNDY yields 6.67% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, DLNDY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLNDY + ABBV for your $10,000?
D&L Industries, Inc. provides products for food ingredients, oleochemicals for personal and home care use, raw materials for plastic, and aerosol products in the Philippines and internationally. The company operates through Food Ingredients; Colorants and Plastic Additives; Oleochemicals, Resins and Powder Coatings; and Consumer Products Original Design Manufacturer (ODM) segments. The Food Ingredients segment manufactures industrial fats and oils, food ingredients, specialty fats and oils, and culinary and other specialty food ingredients to various food manufacturers and quick-service restaurant chains; and food safety solutions, such as cleaning and sanitation agents. The Colorants and Plastic Additives segment manufactures pigment blends, color and additive masterbatches, and engineered polymers for use in the plastic industry, as well as offers toll compounding services. The Oleochemicals, Resins and Powder Coatings segment provides coconut methyl ester; glycerin and other coconut methyl ester derivatives, which are used as surfactants or foaming agents for soaps and detergents; medium-chain triglyceride oil; polystyrene resins for the plastics industry; polymer emulsions for the paint industry; and polyester resins for the construction, shipping, and furniture industries. It also offers powder coatings for use in home appliances, metal furniture, fixtures and fittings, mechanical parts, and tools and equipment, as well as construction industry; and other specialty resin-based chemicals. The Consumer Products ODM segment manufactures aerosol cans and components; products for use in insect control, industrial maintenance chemicals, and home and personal care product applications; and sanitation and hygiene products, such as alcohol, sanitizers, and disinfectant sprays, as well as provides contract aerosol filling and compounding services. The company was founded in 1963 and is headquartered in Quezon City, the Philippines. D&L Industries, Inc. is a subsidiary of Jadel Holdings Co., Inc.
Full DLNDY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.